120 related articles for article (PubMed ID: 32811854)
1. Author Correction: Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models.
Kuo CT; Chen CL; Li CC; Huang GS; Ma WY; Hsu WF; Lin CH; Lu YS; Wo AM
Sci Rep; 2020 Aug; 10(1):14139. PubMed ID: 32811854
[TBL] [Abstract][Full Text] [Related]
2. Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models.
Kuo CT; Chen CL; Li CC; Huang GS; Ma WY; Hsu WF; Lin CH; Lu YS; Wo AM
Sci Rep; 2019 Jul; 9(1):10898. PubMed ID: 31358767
[TBL] [Abstract][Full Text] [Related]
3. Author Correction: Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer.
Luszczak S; Simpson BS; Stopka-Farooqui U; Sathyadevan VK; Echeverria LMC; Kumar C; Costa H; Haider A; Freeman A; Jameson C; Ratynska M; Ben-Salha I; Sridhar A; Shaw G; Kelly JD; Pye H; Gately KA; Whitaker HC; Heavey S
Sci Rep; 2020 Nov; 10(1):19870. PubMed ID: 33177621
[TBL] [Abstract][Full Text] [Related]
4. Author Correction: mTOR at the nexus of nutrition, growth, ageing and disease.
Liu GY; Sabatini DM
Nat Rev Mol Cell Biol; 2020 Apr; 21(4):246. PubMed ID: 32005970
[TBL] [Abstract][Full Text] [Related]
5. Author Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer.
Xu J; Liu Y; Li Y; Wang H; Stewart S; Van der Jeught K; Agarwal P; Zhang Y; Liu S; Zhao G; Wan J; Lu X; He X
Nat Nanotechnol; 2020 Apr; 15(4):342. PubMed ID: 31953520
[TBL] [Abstract][Full Text] [Related]
6. Author Correction: High-protein diets increase cardiovascular risk by activating macrophage mTOR to suppress mitophagy.
Zhang X; Sergin I; Evans TD; Jeong SJ; Rodriguez-Velez A; Kapoor D; Chen S; Song E; Holloway KB; Crowley JR; Epelman S; Weihl CC; Diwan A; Fan D; Mittendorfer B; Stitziel NO; Schilling JD; Lodhi IJ; Razani B
Nat Metab; 2020 Sep; 2(9):991. PubMed ID: 32908252
[TBL] [Abstract][Full Text] [Related]
7. Author Correction: Mammalian Atg8 proteins and the autophagy factor IRGM control mTOR and TFEB at a regulatory node critical for responses to pathogens.
Kumar S; Jain A; Choi SW; da Silva GPD; Allers L; Mudd MH; Peters RS; Anonsen JH; Rusten TE; Lazarou M; Deretic V
Nat Cell Biol; 2020 Oct; 22(10):1286. PubMed ID: 32788721
[TBL] [Abstract][Full Text] [Related]
8. Author Correction: Delivery of acetylthevetin B, an antitumor cardiac glycoside, using polymeric micelles for enhanced therapeutic efficacy against lung cancer cells.
Zhu JJ; Zhang XX; Miao YQ; He SF; Tian DM; Yao XS; Tang JS; Gan Y
Acta Pharmacol Sin; 2020 Sep; 41(9):1261. PubMed ID: 32081943
[TBL] [Abstract][Full Text] [Related]
9. Author Correction: PyMT-1099, a versatile murine cell model for EMT in breast cancer.
Saxena M; Kalathur RKR; Neutzner M; Christofori G
Sci Rep; 2020 Jul; 10(1):11444. PubMed ID: 32632219
[TBL] [Abstract][Full Text] [Related]
10. Author Correction: The highly GABARAP specific rat monoclonal antibody 8H5 visualizes GABARAP in immunofluorescence imaging at endogenous levels.
Simons IM; Mohrlüder J; Feederle R; Kremmer E; Zobel T; Dobner J; Bleffert N; Hoffmann S; Willbold D
Sci Rep; 2019 Dec; 9(1):19221. PubMed ID: 31822784
[TBL] [Abstract][Full Text] [Related]
11. Author Correction: Validating a breast cancer score in Spanish women. The MCC-Spain study.
Dierssen-Sotos T; Gómez-Acebo I; Palazuelos C; Fernández-Navarro P; Altzibar JM; González-Donquiles C; Ardanaz E; Bustamante M; Alonso-Molero J; Vidal C; Bayo-Calero J; Tardón A; Salas D; Marcos-Gragera R; Moreno V; Rodriguez-Cundin P; Castaño-Vinyals G; Ederra M; Vilorio-Marqués L; Amiano P; Pérez-Gómez B; Aragonés N; Kogevinas M; Pollán M; Llorca J
Sci Rep; 2020 Apr; 10(1):5980. PubMed ID: 32238823
[TBL] [Abstract][Full Text] [Related]
12. Author Correction: Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells.
Page BDG; Valerie NCK; Wright RHG; Wallner O; Isaksson R; Carter M; Rudd SG; Loseva O; Jemth AS; Almlöf I; Font-Mateu J; Llona-Minguez S; Baranczewski P; Jeppsson F; Homan E; Almqvist H; Axelsson H; Regmi S; Gustavsson AL; Lundbäck T; Scobie M; Strömberg K; Stenmark P; Beato M; Helleday T
Nat Commun; 2019 Nov; 10(1):5050. PubMed ID: 31676755
[TBL] [Abstract][Full Text] [Related]
13. Author Correction: Notch signaling pathway is a potential therapeutic target for extracranial vascular malformations.
Davis RB; Pahl K; Datto NC; Smith SV; Shawber C; Caron KM; Blatt J
Sci Rep; 2020 Jan; 10(1):1847. PubMed ID: 31996757
[TBL] [Abstract][Full Text] [Related]
14. Author Correction: Neutrophil to lymphocyte ratio and breast cancer risk: analysis by subtype and potential interactions.
Gago-Dominguez M; Matabuena M; Redondo CM; Patel SP; Carracedo A; Ponte SM; Martínez ME; Castelao JE
Sci Rep; 2020 Nov; 10(1):20641. PubMed ID: 33219311
[TBL] [Abstract][Full Text] [Related]
15. Correction: SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway.
Zhang M; Liu S; Chua MS; Li H; Luo D; Wang S; Zhang S; Sun C; Han B
Cell Death Dis; 2019 Oct; 10(11):799. PubMed ID: 31641102
[TBL] [Abstract][Full Text] [Related]
16. Author Correction: Cancer Testis Antigen Promotes Triple Negative Breast Cancer Metastasis and is Traceable in the Circulating Extracellular Vesicles.
Kannan A; Philley JV; Hertweck KL; Ndetan H; Singh KP; Sivakumar S; Wells RB; Vadlamudi RK; Dasgupta S
Sci Rep; 2020 Jan; 10(1):1907. PubMed ID: 32005891
[TBL] [Abstract][Full Text] [Related]
17. Author Correction: G9a regulates breast cancer growth by modulating iron homeostasis through the repression of ferroxidase hephaestin.
Wang YF; Zhang J; Su Y; Shen YY; Jiang DX; Hou YY; Geng MY; Ding J; Chen Y
Nat Commun; 2020 Jul; 11(1):3789. PubMed ID: 32709895
[TBL] [Abstract][Full Text] [Related]
18. Author Correction: Different signatures of miR-16, miR-30b and miR-93 in exosomes from breast cancer and DCIS patients.
Ni Q; Stevic I; Pan C; Müller V; Oliveira-Ferrer L; Pantel K; Schwarzenbach H
Sci Rep; 2019 Dec; 9(1):18700. PubMed ID: 31804497
[TBL] [Abstract][Full Text] [Related]
19. Author Correction: LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer.
Boulding T; McCuaig RD; Tan A; Hardy K; Wu F; Dunn J; Kalimutho M; Sutton CR; Forwood JK; Bert AG; Goodall GJ; Malik L; Yip D; Dahlstrom JE; Zafar A; Khanna KK; Rao S
Sci Rep; 2019 Dec; 9(1):18771. PubMed ID: 31801957
[TBL] [Abstract][Full Text] [Related]
20. Author Correction: Interleukin-6/STAT3 signalling regulates adipocyte induced epithelial-mesenchymal transition in breast cancer cells.
Gyamfi J; Lee YH; Eom M; Choi J
Sci Rep; 2020 Jul; 10(1):13049. PubMed ID: 32724090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
